Fact based stock research
LegoChem Biosciences (KOSDAQ:A141080)
KR7141080002
Research has been discontinued. Contact us if you want research on this stock.
LegoChem Biosciences stock research in summary
There is no stock research analysis by the purely financial fact-based Obermatt method for: LegoChem Biosciences (KOSDAQ:A141080), Life Sciences Tools & Services, South Korea. Contact us if you would like research on this stock.
Latest Obermatt Ranks
Value Rank | n/a | |
Growth Rank | n/a | |
Safety Rank | n/a | |
Combined Rank | n/a |
Country | South Korea |
Industry | Life Sciences Tools & Services |
Index | |
Size class | X-Small |
January 1, 2000. Stock data may be delayed. Login to get the most recent research.
Research History: LegoChem Biosciences
RESEARCH HISTORY | 2019 | 2020 | 2021 | 2022 | ||||
---|---|---|---|---|---|---|---|---|
VALUE | ||||||||
VALUE | n/a |
|
n/a |
|
n/a |
|
n/a |
|
GROWTH | ||||||||
GROWTH | n/a |
|
n/a |
|
n/a |
|
n/a |
|
SAFETY | ||||||||
SAFETY | n/a |
|
n/a |
|
n/a |
|
n/a |
|
COMBINED | ||||||||
COMBINED | n/a |
|
n/a |
|
n/a |
|
n/a |
|
Value Metrics in Detail
VALUE METRICS | 2019 | 2020 | 2021 | 2022 | ||||
---|---|---|---|---|---|---|---|---|
PRICE VS. REVENUES (P/S) | ||||||||
PRICE VS. REVENUES (P/S) | n/a |
|
n/a |
|
n/a |
|
n/a |
|
PRICE VS. PROFITS (P/E) | ||||||||
PRICE VS. PROFITS (P/E) | n/a |
|
n/a |
|
n/a |
|
n/a |
|
PRICE VS. CAPITAL (Market-to-Book) | ||||||||
PRICE VS. CAPITAL (Market-to-Book) | n/a |
|
n/a |
|
n/a |
|
n/a |
|
DIVIDEND YIELD | ||||||||
DIVIDEND YIELD | n/a |
|
n/a |
|
n/a |
|
n/a |
|
CONSOLIDATED RANK: VALUE | ||||||||
CONSOLIDATED RANK: VALUE | n/a |
|
n/a |
|
n/a |
|
n/a |
|
Growth Metrics in Detail
GROWTH METRICS | 2019 | 2020 | 2021 | 2022 | ||||
---|---|---|---|---|---|---|---|---|
REVENUE GROWTH | ||||||||
REVENUE GROWTH | n/a |
|
n/a |
|
n/a |
|
n/a |
|
PROFIT GROWTH | ||||||||
PROFIT GROWTH | n/a |
|
n/a |
|
n/a |
|
n/a |
|
STOCK RETURNS | ||||||||
STOCK RETURNS | n/a |
|
n/a |
|
n/a |
|
n/a |
|
CONSOLIDATED RANK: GROWTH | ||||||||
CONSOLIDATED RANK: GROWTH | n/a |
|
n/a |
|
n/a |
|
n/a |
|
Safety Metrics in Detail
SAFETY METRICS | 2019 | 2020 | 2021 | 2022 | ||||
---|---|---|---|---|---|---|---|---|
LEVERAGE | ||||||||
LEVERAGE | n/a |
|
n/a |
|
n/a |
|
n/a |
|
REFINANCING | ||||||||
REFINANCING | n/a |
|
n/a |
|
n/a |
|
n/a |
|
LIQUIDITY | ||||||||
LIQUIDITY | n/a |
|
n/a |
|
n/a |
|
n/a |
|
CONSOLIDATED RANK: SAFETY | ||||||||
CONSOLIDATED RANK: SAFETY | n/a |
|
n/a |
|
n/a |
|
n/a |
|
Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for LegoChem Biosciences from January 1, 2000.
We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.